Evaluation of skin metabolism of Benzo(a)pyrene : ex vivo skin explant model validation C. Jacques, E.L. Jamin, E. Perdu, S. Bessou-Touya, D. Zalko and.

Slides:



Advertisements
Similar presentations
SITES DRUG BIOTRANSFORMATION
Advertisements

Chemistry Dept, UCONN Identification of Drug Metabolites via Mass Spectrometry Besnik Bajrami Chem 395.
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Biotransformation Xenobiotic metabolism
PRESTIGE’S FUEL SOLUBLE PHASE ACTIVATES THE ARYL HYDROCARBON RECEPTOR Susana CASADO, Mar BABÍN, José V. TARAZONA, José M. NAVAS. Department of the Environment,
Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds.
W507 – Basic toxicokinetics
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Activation/Detoxication. Non-polar (lipophilic) Hydrophobic Lipophobic Hydrophilic (Polar) XENOBIOTIC INTERMEDIATE METABOLITE ELIMINATION WATER-SOLUBLE.
Metabolism of Xenobiotics I. General Overview Aug 25, 2011 L.M. Ball Rosenau 158 ENVR/TOXC 442 Fall 2011.
Factors Affecting Distribution and Metabolism. Chemical Factors Lipophilicity Structure Ionization Chirality.
Drug Detoxification Dr. Howaida Supervised by : Prepared by:
Metabolism of Xenobiotics
Guidance for Industry M4S: The CTD-Safety
Drug Metabolism Overview Dr. Arthur Roberts 1. Where to Find Information eLC – most up to date – correct errors 2.
Biotransformation Xenobiotic metabolism “Essentials of Toxicology” by Klaassen Curtis D. and Watkins John B Chapter 6.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
WP 6 UMR de Toxicologie Alimentaire INRA Dijon WP 6 Cancer : General objectives  inhibition of bio-activation of carcinogens  stimulation of detoxification.
Metabolism - Biotransformation Supplementary readings: Casarett and Doull,Chapter 6 Timbrell, Chapters 4 and 5.
Review of Pharmacokinetics
Mechanisms of Toxicity
XENOBIOTICS The Metabolism of Reported by Group III, 1-C2.
Biochemical functions of liver
TRAINING FOR THE HEALTH SECTOR
NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +
Drug Metabolism and Prodrugs
Absorption, Distribution, Metabolism and Elimination (ADME)
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Mike Comber TIMES-SS Application of Reactivity Principles in Screening for Skin Sensitisers Presented on behalf of the TIMES-SS consortia & International.
WP 6 UMR de Toxicologie Alimentaire INRA WP6 : Effects of garlic on carcinogen metabolizing enzymes Milestones :  In vitro effects of garlic compounds.
Chapter 9 Biotransformation
Section 1, Lecture 4 Phase I reactions-oxidative occur in the endoplasmic reticulum of liver (microsomal fractions) - catalyzed by the microsomal.
!!!……Molecular Target Concept A gonist Antagonist.
1 Environmental impacts and aspects of absorbents used for CO 2 capture Ingvild Eide-Haugmo 1, Karl Anders Hoff 2, Odd Gunnar Brakstad 2, Kristin R. Sørheim.
1 drug molecule Highly lipophyllic lipophilic polar hydrophylic accumulation (fatty tissues) phase I polar phase IIbioinactivation conjugation hydrophylic.
Assessment of Drug Release and Permeation across Skin.
Medical Toxicology Centre Institute of Cellular Medicine Human skin metabolism Past present and future Faith M Williams Newcastle University.
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
Detoxification Chemicals entering body (mostly via food) must pass through liver.
Biotransformation of xenobiotics and endogenous toxins in the liver: microsomal oxidation, cytochrome Р-450.
GARLIC AND HEALTH in vivo Metabolism of DADS 4 th October 2001 Study of in vivo Diallyl disulfide Metabolism Aims of the study : –To determine the pharmacokinetic.
PHT 415 BASIC PHARMACOKINETICS
Emmanuelle Germain, Joelle Chevalier, Marlène Steib, Marie-Hélène Siess* and Caroline Teyssier* Institut National de la Recherche Agronomique / ENSBANA,
Medicinal Chemistry Lecture Drug Metabolism Lectures 11 & 13 Chemical Delivery Systems Joseph O. Oweta | PHS 2201.
Correlation Between the Transdermal Permeation of Ketoprofen and its Solubility in Mixtures of a pH 6.5 Phosphate Buffer and Various Solvents Ref.: Drug.
Zayde Ayvaz 1 and Hasan Huseyin Atar 2 1 Canakkale Onsekiz Mart University, Department of Marine Technology Engineering, Canakkale 17100, Turkey 2 Ankara.
Trophic transfer of microplastics and associated POPs
11 Simulating of in vivo metabolism taking into account detoxification logics.
Antiproliferative effects of trans-resveratrol on HepG2 cells and an evaluation of cell viability method sensitivities. Niousha Ghamami, Mark Gichuru,
Skimune™ Technologies for sensitization and potency assessment   Unique tools for the Cosmetic and Chemical Industries.  
Physiology for Engineers
TLC-UV and TLC-MALDI-TOFMS: an efficient tool for enzyme characterization and screening of bioactive substrates PhD student Justine FEREY INTERNATIONAL.
Results and Discussion
Transportation and Transformation of Xenobiotics
Metabolism - Biotransformation
Mimicking Oxidative Metabolism “OxMet” using ROXY EC System
Metabolism & Detoxification
METABOLISM OF XENOBIOTICS
Drug Elimination Drug elimination consists of 2 processes
OAK CREEK Toxicology & Risk Assessment Consulting
Percutaneous Absorption
Paul van Midwoud, Marjolijn T. Merema,
Biological targets and phase II metabolism of chemopreventive licorice compounds. Biological targets and phase II metabolism of chemopreventive licorice.
Xenobiotic or Drug Metabolism
Ovanes Mekenyan, Milen Todorov, Ksenia Gerova
Drug Detoxification Dr. Howaida Supervised by : Prepared by:
Pharmacokinetics/Pharmacodynamics
Human and Animal Testing: What’s Appropriate
Presentation transcript:

Evaluation of skin metabolism of Benzo(a)pyrene : ex vivo skin explant model validation C. Jacques, E.L. Jamin, E. Perdu, S. Bessou-Touya, D. Zalko and H. Duplan

Skin metabolically active organ (liver reference organ) Physic and Metabolic Barrier biotransformation of xenobiotics Detoxify or bio-activate I. Background and goal

Xenobiotic Activated molecule Conjugated molecule Phase I enzymes Cytochromes P450, flavines mono-oxygenases, alcohols and aldehydes deshydrogenases, esterases, epoxyde hydrolases Phase II enzymes UDP-glucuronyltransferases, sulfotransferases, glutathion-S-transferases, N-acétyltransferases Functionalization Conjugation I. Background and goal

Pig ear skin model : Valuable alternative ex vivo model to animal experiment  In the objective of complying with the European directive 76/768/CEE and with the 3R (reduce, refine, replace) concept for animal experimentation Characterization of metabolic activity of ex vivo pig ear skin model coupled with barrier effect Detailed study of the distribution and metabolism of model xenobiotics Characterization of metabolic activity of ex vivo pig ear skin model coupled with barrier effect Detailed study of the distribution and metabolism of model xenobiotics Similarities with human skin (“gold standard”) (Histological and biochemical properties) Recognized for its use in skin penetration studies I. Background and goal

Benzo(a)pyrene : - polycyclic aromatic hydrocarbon - absorbed following inhalation, oral, and dermal routes - highly metabolized in the liver into several metabolites - in particular, the 7,8-diol-9,10-epoxyde could be responsible of the carcinogenic effect of B(a)P * * [B(a)P]Log K ow 6.35 Choice of model xenobiotics -different physicochemical properties -well-known metabolism -involving Phase I and II enzymes I. Background and goal

Section 500µm thick 6-well plates Inserts 4.1 cm² 1.5ml culture medium domestic pig ear skin (Slaughterhouse) Schema of skin short-term culture Incubation 72 hours 37°C, 5% CO 2 well Skin Explant Insert Culture medium Changed every 24hrs radioactive molecules 50, 100, 200, 400, 600 and 800 nmol Sampling Culture medium : 0, 24, 48, 72 hr All compartments : 72hr II. Experimental approach

Skin explants Inserts Wells Skin surface Liquid scintillation counting Pig ear skin model Culture medium Wells Skin explant Insert Culture medium Skin surface 3 3 II. Experimental approach

Skin explants Inserts Wells Skin surface Liquid scintillation counting Metabolites detection and quantification : Radio-HPLC Metabolites identification : Mass spectrometry, NMR Enzymatic hydrolysis Metabolites detection and quantification : Radio-HPLC Metabolites identification : Mass spectrometry, NMR Enzymatic hydrolysis Pig ear skin model Culture medium II. Experimental approach

Time : 24, 48 et 72 h - Radioactivity: Low doses (25 to 100 nmoles): culture media (46 ± 5% to 85 ± 1%) High doses (200 to 800 nmoels): surface + skin (41 ± 8% to 61 ± 2%) III. Results : quantitative analysis Compartimental radioactivity levels

B(a)P-OHs B(a)P-diones B(a)P-catechols B(a)P-diols B(a)P-tetrols B(a)P B(a)P-OGlcA B(a)P-OSO 3 H B(a)P-diol-SO 3 H B(a)P-diol-GlcA B(a)P B(a)P-OGlcA B(a)P-OSO 3 H B(a)P-OHs B(a)P-diones B(a)P- catechols B(a)P-diols B(a)P-tetrols B(a)P-diol-GlcA B(a)P-diol-SO 3 H Jacques et al. Analytical and Bioanalytical Chemistry (2010). Toxicol Letters (2010) III. Results : Qualitative analysis

B(a)P-Diones Benzo(a)pyrene B(a)P-Epoxydes GSH conjugués B(a)P-Dihydrodiols B(a)P-Dihydrodiolépoxydes GSH conjugués Conjugués glucuronides et sulfates B(a)P-Phénols B(a)P-Phénoldiols B(a)P-Tétrols GSH conjugués B(a)P-Catéchols DNA Adducts Conjugués glucuronides et sulfates Functional enzymes : CYP1A1, CYP1A2, CYP1B1 Epoxyde hydrolase Glucuronyltransferases Sulfotransferases Functional enzymes : CYP1A1, CYP1A2, CYP1B1 Epoxyde hydrolase Glucuronyltransferases Sulfotransferases Jacques et al. Toxicology Letters. (2010). III. Results : BaP metabolic pathway in our skin model

B(a)P dose applied on skin (nmoles) B(a)P metabolites (nmoles/hr) - Major metabolites: glucuronide and sulfates conjugates - Michaelis Menten curves - Enzymatic saturation: 200nmoles of B(a)P III. Results : kinetic of metabolite formation

B(a)P Log K ow 6,5 50 nmoles 400 nmoles 14,5% 21.7% 29,1% 60,8% 23,4% IV. Influence of BaP metabolism on its absorption

Epidermis Dermis Hydrophobic molecule Penetration Stratum Corneum Reservoir Biotransformation Metabolites diffusion Blood stream transfer IV. Influence of BaP metabolism on its absorption

 The percutaneous diffusion rate of a compound depends not only on its physico-chemical properties, but also on the expression of functional enzymes in the skin, especially for hydrophobic compounds like benzo(a)pyrene  Biotransformation at the level of the skin could be an important factor for determining the overall diffusion rate of a xenobiotic  As in the liver, benzo(a)pyrene was metabolized in the skin in several products as diols, tetrols that could induce skin sensitization or skin cancers.  We performed further studies with several known molecules that validated the ex vivo pig ear skin model (testosterone, 7-EC, Caffeine…) Jacques et al; Toxicol In Vitro 2010; SPP 2013 accepted V. Conclusions

Thanks to : Carine Jacques Daniel Bacqueville Sandrine Bessou-Touya Hélène Duplan Daniel Zalko Elisabeth Perdu Jean-Pierre Cravedi Emilien Jamin Laurent Debrauwer INRA UMR 1331